Fig. 1From: Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studiesMean Vital Sign Parameters Over Time: (A) Systolic Blood Pressure (BP), (B) Diastolic BP, and (C) Heart RateBack to article page